Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AMRX vs $CURA.TO | Chartloom

Compare

$AMRX vs $CURA.TO

AMRX

Amneal Pharmaceuticals Inc

CURA.TO

Error

Compare $AMRX vs $CURA.TO

AMRXAmneal Pharmaceuticals Inc

CURA.TO

Error

AMRXAmneal Pharmaceuticals Inc

Market cap

$6.25B

P/E (TTM)

40.80x

Forward P/E (NTM)

19.08x

Forward P/S (NTM)

1.89x

Rev growth (TTM)

9.3%

YTD performance

54.6%

52W performance

96.3%

FCF yield

-0.2%

CURA.TO

Market cap

—

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

—

52W performance

—

FCF yield

—

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AMRX

CURA.TO

Not enough overlapping price history for this window.

Detailed metrics comparison

AMRX

Amneal Pharmaceuticals Inc

CURA.TO

Market Cap

AMRX$6.25B

CURA.TO

Enterprise Value

AMRX$8.85B

CURA.TO

Price

AMRX$19.57

CURA.TO

P/E Ratio

AMRX40.80x

CURA.TO

P/S Ratio

AMRX2.00x

CURA.TO

EV/Sales

AMRX2.84x

CURA.TO

EV/EBITDA

AMRX13.14x

CURA.TO

P/B Ratio

AMRX192.54x

CURA.TO

P/FCF Ratio

AMRXN/A

CURA.TO

EV/FCF

AMRX-719.11x

CURA.TO

PEG Ratio

AMRX1.98x

CURA.TO

Forward P/E (NTM)

AMRX19.08x

CURA.TO

Forward P/S (NTM)

AMRX1.89x

CURA.TO

Revenue (TTM)

AMRX$3.12B

CURA.TO

Revenue Growth (YoY)

AMRX9.3%

CURA.TO

Forward Rev Growth

AMRX9.0%

CURA.TO

Gross Margin (TTM)

AMRX39.3%

CURA.TO

Operating Margin (TTM)

AMRX14.6%

CURA.TO

EBITDA Margin (TTM)

AMRX21.6%

CURA.TO

Net Margin (TTM)

AMRX5.0%

CURA.TO

FCF Margin (TTM)

AMRX-0.4%

CURA.TO

Net Income (TTM)

AMRX$157M

CURA.TO

FCF (TTM)

AMRX$-12M

CURA.TO

EPS (TTM)

AMRX$0.48

CURA.TO

ROE (TTM)

AMRX174.6%

CURA.TO

ROA (TTM)

AMRX4.3%

CURA.TO

ROIC (TTM)

AMRX2.1%

CURA.TO

Cash

AMRX$128M

CURA.TO

Debt

AMRX$2.73B

CURA.TO

Net Cash/Debt

AMRX$-2.60B

CURA.TO

Current Ratio (TTM)

AMRX2.20x

CURA.TO

Quick Ratio (TTM)

AMRX1.38x

CURA.TO

Debt/Equity (TTM)

AMRX82.62x

CURA.TO

Debt/Assets (TTM)

AMRX0.0%

CURA.TO

Interest Coverage (TTM)

AMRXN/A

CURA.TO

Net Debt/EBITDA (TTM)

AMRX0.00x

CURA.TO

Beta

AMRX1.22

CURA.TO

52W Performance

AMRX96.3%

CURA.TO

YTD Performance

AMRX54.6%

CURA.TO

% from 52W High

AMRX-7.6%

CURA.TO

% from 52W Low

AMRX104.7%

CURA.TO

Asset Turnover (TTM)

AMRX0.85x

CURA.TO

FCF Yield (TTM)

AMRX-0.2%

CURA.TO

Earnings Yield (TTM)

AMRX2.5%

CURA.TO

Dividend Yield (TTM)

AMRXN/A

CURA.TO

Rule of 40

AMRX8.9

CURA.TO

EV/GP/RG

AMRX1.16

CURA.TO

Ticker research

View AMRX research View CURA.TO research

Metric	AMRX Amneal Pharmaceuticals Inc	CURA.TO
Market & Valuation
Market Cap	$6.25B
Enterprise Value	$8.85B
Price	$19.57
P/E Ratio	40.80x
P/S Ratio	2.00x
EV/Sales	2.84x
EV/EBITDA	13.14x
P/B Ratio	192.54x
P/FCF Ratio	N/A
EV/FCF	-719.11x
PEG Ratio	1.98x
Forward P/E (NTM)	19.08x
Forward P/S (NTM)	1.89x
Revenue & Growth
Revenue (TTM)	$3.12B
Revenue Growth (YoY)	9.3%
Forward Rev Growth	9.0%
Profitability
Gross Margin (TTM)	39.3%
Operating Margin (TTM)	14.6%
EBITDA Margin (TTM)	21.6%
Net Margin (TTM)	5.0%
FCF Margin (TTM)	-0.4%
Net Income (TTM)	$157M
FCF (TTM)	$-12M
EPS (TTM)	$0.48
ROE (TTM)	174.6%
ROA (TTM)	4.3%
ROIC (TTM)	2.1%
Financial Health
Cash	$128M
Debt	$2.73B
Net Cash/Debt	$-2.60B
Current Ratio (TTM)	2.20x
Quick Ratio (TTM)	1.38x
Debt/Equity (TTM)	82.62x
Debt/Assets (TTM)	0.0%
Interest Coverage (TTM)	N/A
Net Debt/EBITDA (TTM)	0.00x
Performance
Beta	1.22
52W Performance	96.3%
YTD Performance	54.6%
% from 52W High	-7.6%
% from 52W Low	104.7%
Efficiency & Yields
Asset Turnover (TTM)	0.85x
FCF Yield (TTM)	-0.2%
Earnings Yield (TTM)	2.5%
Dividend Yield (TTM)	N/A
Other
Rule of 40	8.9
EV/GP/RG	1.16
Ticker research	View AMRX research	View CURA.TO research

Valuation

Growth & revenue

Profitability & performance

Detailed metrics comparison

AMRX

Amneal Pharmaceuticals Inc

CURA.TO

Market Cap

AMRX$6.25B

CURA.TO

Enterprise Value

AMRX$8.85B

CURA.TO

Price

AMRX$19.57

CURA.TO

P/E Ratio

AMRX40.80x

CURA.TO

P/S Ratio

AMRX2.00x

CURA.TO

EV/Sales

AMRX2.84x

CURA.TO

EV/EBITDA

AMRX13.14x

CURA.TO

P/B Ratio

AMRX192.54x

CURA.TO

P/FCF Ratio

AMRXN/A

CURA.TO

EV/FCF

AMRX-719.11x

CURA.TO

PEG Ratio

AMRX1.98x

CURA.TO

Forward P/E (NTM)

AMRX19.08x

CURA.TO

Forward P/S (NTM)

AMRX1.89x

CURA.TO

Revenue (TTM)

AMRX$3.12B

CURA.TO

Revenue Growth (YoY)

AMRX9.3%

CURA.TO

Forward Rev Growth

AMRX9.0%

CURA.TO

Gross Margin (TTM)

AMRX39.3%

CURA.TO

Operating Margin (TTM)

AMRX14.6%

CURA.TO

EBITDA Margin (TTM)

AMRX21.6%

CURA.TO

Net Margin (TTM)

AMRX5.0%

CURA.TO

FCF Margin (TTM)

AMRX-0.4%

CURA.TO

Net Income (TTM)

AMRX$157M

CURA.TO

FCF (TTM)

AMRX$-12M

CURA.TO

EPS (TTM)

AMRX$0.48

CURA.TO

ROE (TTM)

AMRX174.6%

CURA.TO

ROA (TTM)

AMRX4.3%

CURA.TO

ROIC (TTM)

AMRX2.1%

CURA.TO

Cash

AMRX$128M

CURA.TO

Debt

AMRX$2.73B

CURA.TO

Net Cash/Debt

AMRX$-2.60B

CURA.TO

Current Ratio (TTM)

AMRX2.20x

CURA.TO

Quick Ratio (TTM)

AMRX1.38x

CURA.TO

Debt/Equity (TTM)

AMRX82.62x

CURA.TO

Debt/Assets (TTM)

AMRX0.0%

CURA.TO

Interest Coverage (TTM)

AMRXN/A

CURA.TO

Net Debt/EBITDA (TTM)

AMRX0.00x

CURA.TO

Beta

AMRX1.22

CURA.TO

52W Performance

AMRX96.3%

CURA.TO

YTD Performance

AMRX54.6%

CURA.TO

% from 52W High

AMRX-7.6%

CURA.TO

% from 52W Low

AMRX104.7%

CURA.TO

Asset Turnover (TTM)

AMRX0.85x

CURA.TO

FCF Yield (TTM)

AMRX-0.2%

CURA.TO

Earnings Yield (TTM)

AMRX2.5%

CURA.TO

Dividend Yield (TTM)

AMRXN/A

CURA.TO

Rule of 40

AMRX8.9

CURA.TO

EV/GP/RG

AMRX1.16

CURA.TO

Ticker research

View AMRX research View CURA.TO research

Metric	AMRX Amneal Pharmaceuticals Inc	CURA.TO
Market & Valuation
Market Cap	$6.25B
Enterprise Value	$8.85B
Price	$19.57
P/E Ratio	40.80x
P/S Ratio	2.00x
EV/Sales	2.84x
EV/EBITDA	13.14x
P/B Ratio	192.54x
P/FCF Ratio	N/A
EV/FCF	-719.11x
PEG Ratio	1.98x
Forward P/E (NTM)	19.08x
Forward P/S (NTM)	1.89x
Revenue & Growth
Revenue (TTM)	$3.12B
Revenue Growth (YoY)	9.3%
Forward Rev Growth	9.0%
Profitability
Gross Margin (TTM)	39.3%
Operating Margin (TTM)	14.6%
EBITDA Margin (TTM)	21.6%
Net Margin (TTM)	5.0%
FCF Margin (TTM)	-0.4%
Net Income (TTM)	$157M
FCF (TTM)	$-12M
EPS (TTM)	$0.48
ROE (TTM)	174.6%
ROA (TTM)	4.3%
ROIC (TTM)	2.1%
Financial Health
Cash	$128M
Debt	$2.73B
Net Cash/Debt	$-2.60B
Current Ratio (TTM)	2.20x
Quick Ratio (TTM)	1.38x
Debt/Equity (TTM)	82.62x
Debt/Assets (TTM)	0.0%
Interest Coverage (TTM)	N/A
Net Debt/EBITDA (TTM)	0.00x
Performance
Beta	1.22
52W Performance	96.3%
YTD Performance	54.6%
% from 52W High	-7.6%
% from 52W Low	104.7%
Efficiency & Yields
Asset Turnover (TTM)	0.85x
FCF Yield (TTM)	-0.2%
Earnings Yield (TTM)	2.5%
Dividend Yield (TTM)	N/A
Other
Rule of 40	8.9
EV/GP/RG	1.16
Ticker research	View AMRX research	View CURA.TO research